Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in New Jersey
| Provider | Medicare | Services |
|---|---|---|
| Siparadigm Llc | $38.99 | 3.0K |
| Rotolo, James M.D. | $38.98 | 663 |
| Cairo Diagnostics Nj, Llc | $36.29 | 207 |
| Leitner, Robyn M.D. | $38.93 | 200 |
| Fitzgerald, Carrie DO MPH | $39.96 | 90 |
| Mobilio, Jeffrey | $32.84 | 89 |
| Burzon, Daniel MD | $39.05 | 80 |
| Mazziotta, Robert M.D. | $40.18 | 58 |
| Antario, Joseph UROLOGIST | $37.80 | 56 |
| Pathline , Llc | $39.50 | 56 |
| Howard, Michael M.D. | $39.05 | 50 |
| Simon, Andrew M.D. | $35.61 | 49 |
| Taskin, Metin MD | $40.18 | 44 |
| Chapman, John MD | $39.05 | 42 |
| Perlmutter, Mark M.D. | $37.87 | 33 |
| Fam, Mina MD | $37.66 | 28 |
| Depalma, John DO | $37.28 | 22 |
| Bickerton, Michael MD | $37.69 | 15 |
New Jersey Pricing in Context
In New Jersey, CPT code G0452 (Molecular Pathology Procedure; Physician Interpretation And Report) carries an average Medicare payment of $38.69 — 6% above the national benchmark of $36.63. 55 providers across the state submitted claims for this procedure in 2023, performing 7.0K total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in New Jersey is $210.48, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Temporary Procedures procedures, the estimated commercial insurance price in New Jersey lands near $126.56, with self-pay cash prices typically around $95.10. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Molecular Pathology Procedure; Physician Interpretation And Report cost in New Jersey?
The average Medicare payment for Molecular Pathology Procedure; Physician Interpretation And Report in New Jersey is $38.69, which is 6% above the national average of $36.63. Providers in NJ typically bill $210.48 for this procedure.
What does Molecular Pathology Procedure; Physician Interpretation And Report cost with insurance in New Jersey?
With commercial insurance in New Jersey, Molecular Pathology Procedure; Physician Interpretation And Report costs an estimated $126.56. Without insurance, the estimated cash price is $95.10. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Molecular Pathology Procedure; Physician Interpretation And Report in New Jersey?
55 providers in New Jersey billed Medicare for Molecular Pathology Procedure; Physician Interpretation And Report in 2023, performing 7.0K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Molecular Pathology Procedure; Physician Interpretation And Report cheaper in New Jersey than the national average?
No — Molecular Pathology Procedure; Physician Interpretation And Report costs 6% above the national average in New Jersey. The state average Medicare payment is $38.69 compared to $36.63 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.